Hoffert Y, Wang Z, Fumery M, Nachury M, et al. A Risk Stratification Tool for Relapse After Intravenous-To-Subcutaneous Switching of Infliximab in Patients With Inflammatory Bowel Diseases. Am J Gastroenterol 2026;121:179-186.
PMID: 40192145